Stay updated on Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section now distinguishes between volunteer-provided publications and those automatically filled from PubMed. It also records Revision: v3.3.2.SummaryDifference0.4%

- Check28 days agoChange DetectedDeletion of the government funding and NIH operating status notice that previously informed users about potential delays and where to check status (cc.nih.gov, opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedNo substantive differences detected between the old and new screenshots. The Study Details page content and structure appear unchanged.SummaryDifference0.3%

- Check71 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

- Check78 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.3%

- Check92 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.